Novo Nordisk Invests $4.1 Billion in New US Manufacturing Site, Abandoning Irish Plans

1. Investment Amount: Novo Nordisk is investing $4.1 billion in a new US manufacturing site.
2. Location: The new site will be located in Clayton, North Carolina.
3. Purpose: The facility will focus on manufacturing obesity drugs.
4. Facility Type: It will be a second fill-finish facility.
5. Abandoned Plans: Novo Nordisk has abandoned its plans to build a manufacturing site in Ireland.
6. Boosting US Manufacturing: This investment is part of the company's efforts to further boost its manufacturing capabilities in the US.